ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

INTRODUCTION: UK guidelines recommend that all early active rheumatoid arthritis (RA) patients are offered combination disease-modifying antirheumatic drugs (DMARDs) and short-term corticosteroids. Anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative RA may differ in their treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Seegobin, Seth D, Ma, Margaret HY, Dahanayake, Chanaka, Cope, Andrew P, Scott, David L, Lewis, Cathryn M, Scott, Ian C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979097/
https://www.ncbi.nlm.nih.gov/pubmed/24433430
http://dx.doi.org/10.1186/ar4439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979097/
https://www.ncbi.nlm.nih.gov/pubmed/24433430
http://dx.doi.org/10.1186/ar4439

Ejemplares similares